iRobot 2014 Annual Report Download - page 10

Download and view the complete annual report

Please find page 10 of the 2014 iRobot annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 152

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152

4
Australian investment offerings. The address of each reporting entity is 100 Vanguard Boulevard, Malvern, PA 19355. This
information has been obtained from a Schedule 13G/A filed by The Vanguard Group, Inc. with the Securities and Exchange
Commission on February 10, 2015.
(5) T. Rowe Price Associates, Inc. has sole voting power with respect to 391,600 shares and sole dispositive power with respect to
1,669,000 shares. This information has been obtained from a Schedule 13G filed by T. Rowe Price Associates, Inc. with the
Securities and Exchange Commission on February 13, 2015. The address of T. Rowe Price Associates, Inc. is 100 E. Pratt
Street, Baltimore, MD 21202.
(6) Includes 290,480 shares issuable to Mr. Angle upon exercise of stock options and 5,700 shares issuable to Mr. Angle upon
vesting of restricted stock units.
(7) Includes 32,888 shares issuable to Ms. Dean upon exercise of stock options and 931 shares issuable to Ms. Dean upon vesting
of restricted stock units.
(8) Includes 50,152 shares issuable to Mr. Campanello upon exercise of stock options.
(9) Includes 65,059 shares issuable to Dr. Pirjanian upon exercise of stock options.
(10) Includes 22,035 shares issuable to Mr. Weinstein upon exercise of stock options and 1,437 shares issuable to Mr. Weinstein
upon vesting of restricted stock units.
(11) Includes 31,798 shares issuable to Mr. Cerda upon exercise of stock options.
(12) Includes an aggregate of 140,000 shares held by iD5 Fund, L.P. Dr. Chwang is a general partner of the management company
for iD5 Fund, L.P. and may be deemed to share voting and investment power with respect to all shares held by iD5 Fund, L.P.
Dr. Chwang disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any. Also includes
30,000 shares issuable to Dr. Chwang upon exercise of stock options, 3,243 shares issuable to Dr. Chwang upon vesting of
restricted stock options and 79,210 shares held in a trust for the benefit of certain of his family members. As co-trustees of the
family trust, Dr. Chwang shares voting and dispositive power over the shares held by the trust with his spouse.
(13) Includes 3,243 shares issuable to Ms. Deegan upon vesting of restricted stock units.
(14) Includes 3,243 shares issuable to Ms. Ellinger upon vesting of restricted stock units.
(15) Includes 40,000 shares issuable to Mr. Geisser upon exercise of stock options, 3,243 shares issuable to Mr. Geisser upon
vesting of restricted stock units and 12,643 shares issuable to Mr. Geisser upon termination of service.
(16) Includes 70,000 shares issuable to Mr. McNamee upon exercise of stock options, 3,243 shares issuable to Mr. McNamee upon
vesting of restricted stock units and 3,487 shares issuable to Mr. McNamee upon termination of service.
(17) Includes 60,000 shares issuable to Gen. Kern upon exercise of stock options, 3,243 shares issuable to Gen. Kern upon vesting
of restricted stock units and 8,492 shares issuable to Gen. Kern upon termination of service.
(18) Includes 2,500 shares issuable to Mr. Sagan upon exercise of stock options, 3,243 shares issuable to Mr. Sagan upon vesting of
restricted stock units and 4,767 shares issuable to Mr. Sagan upon termination of service.
(19) Includes an aggregate of 694,912 shares issuable upon exercise of stock options held by eleven executive officers and
directors, an aggregate of 30,769 shares issuable upon vesting of restricted stock units held by ten executive officers and
directors and an aggregate of 29,389 shares issuable upon termination of service to four (4) directors.